Results 91 to 100 of about 519,396 (228)
BackgroundCorticosteroids are extensively used in ophthalmology, particularly for treating various inflammatory conditions. Despite their effectiveness, prolonged or high-dose corticosteroid use is associated with significant adverse drug reactions (ADRs)
Chengzhi Liu, Xinyu Wang, Xusheng Cao
doaj +1 more source
BackgroundThere have been reports of otolaryngological adverse event following immunization (AEFI) such as instances of olfactory and gustatory dysfunction following COVID-19 vaccination.
Jieun Shin +8 more
doaj +1 more source
Signal mining of adverse events of proteasome inhibitors in multiple myeloma based on FAERS
ObjectiveTo mine and analyze adverse events (AEs) related to proteasome inhibitors in multiple myeloma based on the FDA Adverse Event Reporting System (FAERS), providing references for rational clinical medication.MethodsAE data related to multiple ...
Yuan Peng +5 more
doaj +1 more source
Patient safety in Europe: medication errors and hospital-acquired infections [PDF]
The Report was commissioned by the European Federation of Nurses Associations (EFN) in November 2007 in order to support its policy statements on Patient Safety (June 2004).
Burke, J. +3 more
core +1 more source
Explaining Aviation Safety Incidents Using Deep Temporal Multiple Instance Learning
Although aviation accidents are rare, safety incidents occur more frequently and require a careful analysis to detect and mitigate risks in a timely manner.
Avila Garcez A. S. +5 more
core +1 more source
IntroductionTaste disorders, which can diminish the quality of life and potentially affect drug treatment efficacy, are adverse events that may occur with the use of various medications; however, only a few studies have comprehensively examined this ...
Yoji Kyotani +2 more
doaj +1 more source
Medical errors: Mandatory reporting, voluntary reporting, or both? [PDF]
This work evaluates policy recommendations on medical error reporting systems presented in, To err is human, a report published by the Institute of Medicine.
Grepperud, Sverre
core
BackgroundTeprotumumab, an IGF-1R monoclonal antibody, has shown significant efficacy in treating thyroid eye disease (TED). However, since teprotumumab was launched in 2020 and first approved in the United States, there were limited reports of post ...
Jiawei Zhao, Yong Tao
doaj +1 more source
Background: Anti-Calcitonin gene-related peptide monoclonal antibodies (anti-CGRP mAbs) have shown significant efficacy in preventing migraine. However, there have been limited reports of adverse events (AEs) after marketing, particularly for eptinezumab
Wenfang Sun +7 more
doaj +1 more source

